Stock DBD DIEBOLD NIXDORF, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Diebold Nixdorf, Incorporated

Equities

DBD

US2536512021

Real-time Estimate Cboe BZX
Other stock markets
 12:35:41 2024-05-13 pm EDT 		5-day change 1st Jan Change
41.96 USD +2.33% Intraday chart for Diebold Nixdorf, Incorporated +9.32% +45.39%
04:47pm Diebold Nixdorf, Bankart Collaborate to Revamp Payment Processing in Southeast Europe MT
May. 03 Wedbush Upgrades Diebold Nixdorf to Outperform From Neutral, Raises Price Target to $50 From $40 MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wedbush Upgrades Diebold Nixdorf to Outperform From Neutral, Raises Price Target to $50 From $40
MT
Wedbush Raises Diebold Nixdorf's PT to $40 From $25 After Debt Repayment, 'Strong' Q4 2023 Execution; Keeps Neutral Rating
MT
DA Davidson Upgrades Diebold Nixdorf to Buy From Neutral, Raises Price Target to $29 From $25
MT
Wedbush Raises Diebold Nixdorf's PT to $25 From $20 in Light of Higher Earnings Expectations Moving Forward, Keeps Neutral Rating
MT
Wedbush Raises Diebold Nixdorf's PT to $20 From $1 After Exiting Bankruptcy, Notes Improved Capital Structure; Keeps Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DBD Stock
  4. News Diebold Nixdorf, Incorporated
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW